News
The multinational pharma company will access Tempus' AI-enabled data library to further therapeutic development and advance its portfolio in oncology.
The digital health company reported $184.1 million in revenue for Q4, a 14% decline from the same period in 2021.
The wearable uses its motion sensors to determine if the user has taken a hard fall and can contact emergency services if they don't respond.
The mental health platform let go of 15% of its workforce.
The company had previously received FDA clearance to use its prescription wearable to treat migraines at onset.
DenovAI will create an AI-powered platform to discover potential antibodies from scratch, then suggest which ones can be used as effective drugs.
The company reported $526.9 million in revenue last year compared with $271.9 million in 2021.
Rock Health’s 2022 Digital Health Consumer Adoption Survey also found non-video telehealth offerings have become more popular.
Lucira's diagnostic is the first over-the-counter at-home combination test for COVID-19 and flu authorized by the FDA.
A Pew Research Center survey of more than 11,000 U.S. adults reveals the majority would feel uncomfortable if their healthcare provider relied on AI for their care.